CytomX Therapeutics' Series D Round

CytomX Therapeutics raised a round of funding on June 17, 2015.

CytomX Therapeutics is a biotechnology company developing Probody therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specif…

Articles about CytomX Therapeutics' Series D Round: